查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601291

STD 檢測市場：按類型、按產品類型、按測試設定、按適應症、按最終用戶 - 2025-2030 年全球預測

STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Product Type (Instruments, Reagents & Kits), Test Settings, Indication, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年性病檢測市場價值為94.4億美元，預計到2024年將達到99.7億美元，複合年成長率為5.90%，到2030年將達到141.1億美元。

性病檢測市場包括各種旨在檢測性行為感染傳染病的診斷檢測，包括但不限於披衣菌感染、淋病、愛滋病毒和梅毒。感染率上升、公眾健康意識提高以及早期診斷和治療性介入的努力推動了對性病檢測的需求。其應用涵蓋醫院、診所和居家照護，最終用戶是醫療保健提供者、個人消費者和公共衛生機構。該市場受到許多因素的顯著影響，例如實現快速準確檢測的技術進步、政府對性病檢測宣傳活動的支持力度加大以及對家庭和數位醫療保健解決方案的接受程度不斷提高。這些因素為市場參與企業在遠端醫療整合、基於行動應用程式的測試解決方案以及開發更靈敏和特異性的檢測等領域創造了創新機會。然而，市場成長受到圍繞性傳染病的恥辱、低度開發地區缺乏認知以及監管核准和報銷政策問題的限制。為了解決這些問題，公司可以投資教育行銷宣傳活動，與公共衛生機構合作，並專注於研究具有成本效益的檢測解決方案。創新的關鍵領域包括小型化診斷平台，用於在資源有限的環境中進行測試，以及將人工智慧應用於性病感染模式的預測分析。此外，透過培養與科技公司的夥伴關係，我們可以進一步增強準確測試服務的提供。市場的動態本質需要敏捷性和遠見，而多重測試和個人化醫療服務等新趨勢需要高度關注。跟上醫療保健資金籌措的監管變化和潛在政策變化對於永續業務成長和競爭力至關重要。

主要市場統計
基準年[2023] 94.4億美元
預測年份 [2024] 99.7億美元
預測年份 [2030] 141.1億美元
複合年成長率（%） 5.90%

市場動態：揭示快速發展的性病檢測市場的關鍵市場洞察

供需的動態交互作用正在改變性病檢測市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球性行為感染感染的發生率和盛行率不斷上升
    • 透過教育宣傳活動提高對性傳染病的認知
  • 市場限制因素
    • 有關核准性病檢測產品的嚴格監管指南的問題
  • 市場機會
    • 性病診斷技術不斷進步
    • 加大全國篩檢檢測力度，促進性病檢測的採用
  • 市場挑戰
    • 前往專門從事性病檢測的診所會帶來社會恥辱

波特五力：駕馭性病檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解性病檢測市場的外部影響

外部宏觀環境因素對性病檢測市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解性病檢測市場的競爭狀況

STD 測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣STD偵測市場供應商績效評估

FPNV定位矩陣是評估STD檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球性行為感染傳染病的發生率和盛行率不斷增加
      • 透過教育宣傳活動提高對性行為感染的認知
    • 抑制因素
      • 核准性病檢測產品的嚴格監管指南存在問題
    • 機會
      • 性行為感染傳染病診斷技術不斷進步
      • 增加全國的篩檢檢測並鼓勵採用性病檢測
    • 任務
      • 與看專科醫生相關的社會恥辱
  • 市場區隔分析
    • 類型：STD 檢測 拭子檢測越來越受歡迎，因為它們是非侵入性的
    • 產品類型：需要用於大容量測試環境的高通量設備
    • 測試設定：優先進行 POC 測試，以獲得無與倫比的便利性和速度
    • 適應症：披衣菌感染發病率增加以及對先進檢測技術的需求
    • 最終用戶：擴大診斷中心性病檢測的使用並減少週轉時間
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章性病檢測市場：依類型

  • 驗血
  • 腰椎穿刺
  • 拭子測試
  • 尿液檢查

第7章性病檢測市場：依產品類型

  • 裝置
  • 試劑和套件

第8章性病檢測市場（依檢測環境）

  • 實驗室
  • 照護現場

第9章性病檢測市場（按適應症）

  • 披衣菌感染
  • 生殖器皰疹
  • 淋病
  • B型肝炎
  • 愛滋病毒/愛滋病
  • 人類乳突病毒
  • 梅毒

第 10 章 STD 檢測市場：依最終用戶分類

  • 診斷中心
  • 醫院/診所

第11章 南北美洲性病檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區性病檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲性病檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 策略夥伴關係推進性行為感染傳染病自檢解決方案
    • imaware 透過收購 binx health 的消費者部門擴大產品組合
    • FDA核准先進的披衣菌感染和淋病家庭檢測
    • 英國Start-Ups推出性行為感染感染測試功能的衛生棉條
    • iHealth 推出 STD 檢測的家庭採集套件
    • Aptitude Medical Systems 消除性行為感染感染 (STI) 的創新方法
    • LifeCell International 透過家用檢測套組徹底改變了性行為感染傳染病和 HPV 檢測
    • Linear Diagnostics 開創性的 20 分鐘淋病和披衣菌感染檢測
    • 美國 BioTek 創新的家庭檢測解決方案
    • Visbee Medical 先進性健康診斷工具獲得 FDA 批准
    • Mylab 推出性行為感染傳染病快速檢測系列
    • Maternova 和 Medmira 策略聯盟加強全球感染疾病快速診斷檢測
    • 創新夥伴關係關係透過家庭檢測解決方案來應對 Z 世代性行為感染感染激增問題
    • Meridian Biosciences 與 SD Biosensors 和 SJL Partners 合作

公司名單

  • Abbott Laboratories
  • Accuquik by AdvaCare Pharma
  • Alpine Biomedicals Pvt. Ltd.
  • ARCpoint Labs
  • Becton, Dickinson and Company
  • Bio Lab Diagnostics（I）Private Limited
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioReference Health, LLC by OPKO HEALTH, INC.
  • Danaher Corporation
  • Daye Limited
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Grifols, SA
  • Hologic, Inc.
  • JAL Medical by OK Biotech Co. Ltd.
  • Laboratory Corporation of America Holdings
  • LifeCell
  • Lorne Laboratories Limited by Calibre Scientific
  • Meridian Bioscience Inc. by SD Biosensor, Inc.
  • OraSure Technologies, Inc.
  • Personalabs
  • Qiagen NV
  • Quest Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Viatris Inc.
  • Wondfo Biotech Co., Ltd.
Product Code: MRR-69324464D0F2

The STD Testing Market was valued at USD 9.44 billion in 2023, expected to reach USD 9.97 billion in 2024, and is projected to grow at a CAGR of 5.90%, to USD 14.11 billion by 2030.

The STD testing market encompasses a wide array of diagnostic tests designed to detect sexually transmitted diseases, including, but not limited to, chlamydia, gonorrhea, HIV, and syphilis. The necessity for STD testing stems from rising infection rates, greater public health awareness, and initiatives for early diagnosis and treatment intervention. Its application spans hospitals, clinics, and homecare settings, with end-users comprising healthcare providers, individual consumers, and public health organizations. The market is significantly influenced by factors such as technological advancements enabling rapid and accurate testing, increased government support for STD testing campaigns, and growing acceptance of at-home and digital healthcare solutions. These factors create opportunities for market players to innovate in areas such as telehealth integration, mobile app-based testing solutions, and the development of more sensitive and specific assays. However, market growth is challenged by limitations such as stigma surrounding STDs, lack of awareness in underdeveloped regions, and issues related to regulatory approvals and reimbursement policies. To address these, businesses could invest in educational marketing campaigns, collaborate with public health entities, and focus on research for cost-effective testing solutions. Key areas of innovation include the miniaturization of diagnostic platforms for testing in resource-limited settings and the application of AI for predictive analyses in STD transmission patterns. Additionally, fostering partnerships with technology firms can further enhance the delivery of precise testing services. The market's dynamic nature necessitates agility and foresight, with significant attention needed on emerging trends like multiplex testing and personalized healthcare delivery. Keeping pace with regulatory changes and potential policy shifts in healthcare funding will be essential for sustained business growth and establishing a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 9.44 billion
Estimated Year [2024] USD 9.97 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 5.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving STD Testing Market

The STD Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence and prevalence of sexually transmitted diseases worldwide
    • Increasing awareness about STDs through education campaigns
  • Market Restraints
    • Issues regarding strict regulatory guidelines for approval of STD testing products
  • Market Opportunities
    • Ongoing technical advancements in STD disease diagnostics
    • Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
  • Market Challenges
    • Social stigma associated with visiting specialized STD testing clinics

Porter's Five Forces: A Strategic Tool for Navigating the STD Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the STD Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the STD Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the STD Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the STD Testing Market

A detailed market share analysis in the STD Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the STD Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the STD Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuquik by AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., ARCpoint Labs, Becton, Dickinson and Company, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., bioMerieux SA, BioReference Health, LLC by OPKO HEALTH, INC., Danaher Corporation, Daye Limited, Everlywell, Inc., F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Grifols, S.A., Hologic, Inc., JAL Medical by OK Biotech Co. Ltd., Laboratory Corporation of America Holdings, LifeCell, Lorne Laboratories Limited by Calibre Scientific, Meridian Bioscience Inc. by SD Biosensor, Inc., OraSure Technologies, Inc., Personalabs, Qiagen N.V., Quest Diagnostics, Inc., Randox Laboratories Ltd., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Viatris Inc., and Wondfo Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Blood Tests, Lumbar Puncture, Swab Tests, and Urine Tests.
  • Based on Product Type, market is studied across Instruments and Reagents & Kits.
  • Based on Test Settings, market is studied across Laboratory and Point of Care.
  • Based on Indication, market is studied across Chlamydia, Genital Herpes, Gonorrhea, Hepatitis B, HIV/AIDS, Human Papillomavirus, and Syphilis.
  • Based on End-user, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
      • 5.1.1.2. Increasing awareness about STDs through education campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technical advancements in STD disease diagnostics
      • 5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for swab tests for STD testing for their non-invasive nature
    • 5.2.2. Product Type: Need for high-throughput instruments for high-volume testing environments
    • 5.2.3. Test Settings: Preference for POC tests for their unmatched convenience and speed
    • 5.2.4. Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies
    • 5.2.5. End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. STD Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Lumbar Puncture
  • 6.4. Swab Tests
  • 6.5. Urine Tests

7. STD Testing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Kits

8. STD Testing Market, by Test Settings

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. Point of Care

9. STD Testing Market, by Indication

  • 9.1. Introduction
  • 9.2. Chlamydia
  • 9.3. Genital Herpes
  • 9.4. Gonorrhea
  • 9.5. Hepatitis B
  • 9.6. HIV/AIDS
  • 9.7. Human Papillomavirus
  • 9.8. Syphilis

10. STD Testing Market, by End-user

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals & Clinics

11. Americas STD Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific STD Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa STD Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Alliance Advances Self-Test Solutions for Sexually Transmitted Diseases
    • 14.3.2. imaware Expands its Portfolio through binx health's Consumer Division Purchase
    • 14.3.3. FDA Approves Advanced At-home Chlamydia and Gonorrhea Test
    • 14.3.4. British Startup Launches Tampon That Offers STI Screening
    • 14.3.5. iHealth Launches Home Collection Kit for STD Testing
    • 14.3.6. Aptitude Medical Systems' Innovative Approach to Combat Sexually Transmitted Infections (STIs)
    • 14.3.7. LifeCell International Revolutionizes STD and HPV Screening with At-Home Test Kits
    • 14.3.8. Breakthrough 20-Minute Test for Gonorrhea and Chlamydia by Linear Diagnostics
    • 14.3.9. US BioTek's Innovative At-Home Testing Solutions
    • 14.3.10. Visby Medical Achieves FDA Clearance for Advanced Sexual Health Diagnostic Tool
    • 14.3.11. Mylab Launches a Range of Rapid Tests for STDs
    • 14.3.12. Strategic Partnership between Maternova and MedMira Enhances Global Access to Rapid Diagnostic Tests for Infectious Diseases
    • 14.3.13. Innovative Partnership Tackles STI Spike Among Gen Z with At-Home Testing Solutions
    • 14.3.14. Meridian Bioscience Joins Forces with SD Biosensor and SJL Partners

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accuquik by AdvaCare Pharma
  • 3. Alpine Biomedicals Pvt. Ltd.
  • 4. ARCpoint Labs
  • 5. Becton, Dickinson and Company
  • 6. Bio Lab Diagnostics (I) Private Limited
  • 7. Bio-Rad Laboratories, Inc.
  • 8. bioMerieux SA
  • 9. BioReference Health, LLC by OPKO HEALTH, INC.
  • 10. Danaher Corporation
  • 11. Daye Limited
  • 12. Everlywell, Inc.
  • 13. F. Hoffmann-La Roche Ltd.
  • 14. Getein Biotech, Inc.
  • 15. Grifols, S.A.
  • 16. Hologic, Inc.
  • 17. JAL Medical by OK Biotech Co. Ltd.
  • 18. Laboratory Corporation of America Holdings
  • 19. LifeCell
  • 20. Lorne Laboratories Limited by Calibre Scientific
  • 21. Meridian Bioscience Inc. by SD Biosensor, Inc.
  • 22. OraSure Technologies, Inc.
  • 23. Personalabs
  • 24. Qiagen N.V.
  • 25. Quest Diagnostics, Inc.
  • 26. Randox Laboratories Ltd.
  • 27. Seegene Inc.
  • 28. Siemens Healthineers AG
  • 29. Thermo Fisher Scientific Inc.
  • 30. Viatris Inc.
  • 31. Wondfo Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STD TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023